These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 11890660)

  • 1. Antagonising angiogenesis in rheumatoid arthritis.
    Brenchley PE
    Ann Rheum Dis; 2001 Nov; 60 Suppl 3(Suppl 3):iii71-4. PubMed ID: 11890660
    [No Abstract]   [Full Text] [Related]  

  • 2. [The role of angiogenesis in rheumatoid arthritis].
    Pałgan K
    Postepy Hig Med Dosw; 2000; 54(6):855-65. PubMed ID: 11227381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Angiogenic heterogeneity: regulation of neoplastic angiogenesis by the organ microenvironment.
    Fidler IJ
    J Natl Cancer Inst; 2001 Jul; 93(14):1040-1. PubMed ID: 11459857
    [No Abstract]   [Full Text] [Related]  

  • 4. Does vascular endothelial growth factor in the rheumatoid synovium predict joint destruction? A clinical, radiological, and pathological study in 12 patients monitored for 10 years.
    Latour F; Zabraniecki L; Dromer C; Brouchet A; Durroux R; Fournié B
    Joint Bone Spine; 2001 Dec; 68(6):493-8. PubMed ID: 11808986
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous inhibitors of angiogenesis.
    Ruhrberg C
    J Cell Sci; 2001 Sep; 114(Pt 18):3215-6. PubMed ID: 11591810
    [No Abstract]   [Full Text] [Related]  

  • 6. Surgical implications of therapeutic angiogenesis.
    Zimmerman MA; Selzman CH; Harken AH
    Surgery; 1999 Mar; 125(3):243-9. PubMed ID: 10076607
    [No Abstract]   [Full Text] [Related]  

  • 7. The basic residues of placenta growth factor type 2 retrieve sequestered angiogenic factors into a soluble form: implications for tumor angiogenesis.
    Barillari G; Albonici L; Franzese O; Modesti A; Liberati F; Barillari P; Ensoli B; Manzari V; Santeusanio G
    Am J Pathol; 1998 May; 152(5):1161-6. PubMed ID: 9588884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of growth factor production and angiogenesis in human cancer cells by ZD1839 (Iressa), a selective epidermal growth factor receptor tyrosine kinase inhibitor.
    Ciardiello F; Caputo R; Bianco R; Damiano V; Fontanini G; Cuccato S; De Placido S; Bianco AR; Tortora G
    Clin Cancer Res; 2001 May; 7(5):1459-65. PubMed ID: 11350918
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Advances in the use of angiogenesis inhibitors in cancer.
    Pinedo HM
    Cancer J; 2001; 7 Suppl 3():S107-8. PubMed ID: 11779080
    [No Abstract]   [Full Text] [Related]  

  • 10. Nitric oxide mediates interleukin-1-induced matrix degradation and basic fibroblast growth factor release in cultured rabbit articular chondrocytes: a possible mechanism of pathological neovascularization in arthritis.
    Tamura T; Nakanishi T; Kimura Y; Hattori T; Sasaki K; Norimatsu H; Takahashi K; Takigawa M
    Endocrinology; 1996 Sep; 137(9):3729-37. PubMed ID: 8756539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Imbalance in production between vascular endothelial growth factor and endostatin in patients with rheumatoid arthritis.
    Nagashima M; Asano G; Yoshino S
    J Rheumatol; 2000 Oct; 27(10):2339-42. PubMed ID: 11036826
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incipient angiogenesis.
    Folkman J
    J Natl Cancer Inst; 2000 Jan; 92(2):94-5. PubMed ID: 10639502
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors promoting tumor angiogenesis.
    Beckner ME
    Cancer Invest; 1999; 17(8):594-623. PubMed ID: 10592767
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiogenic cytokines in cartilage tumors.
    McGough RL; Lin C; Meitner P; Aswad BI; Terek RM
    Clin Orthop Relat Res; 2002 Apr; (397):62-9. PubMed ID: 11953596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Angiogenesis in acute and chronic leukemias.
    Dickson DJ; Shami PJ
    Leuk Lymphoma; 2001; 42(5):847-53. PubMed ID: 11697639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis.
    Yin G; Liu W; An P; Li P; Ding I; Planelles V; Schwarz EM; Min W
    Mol Ther; 2002 May; 5(5 Pt 1):547-54. PubMed ID: 11991745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ocular angiogenesis; a new in vivo experimental model.
    Grignolo FM; Emanuelli L; Eandi CM; Brogliatti B
    Acta Ophthalmol Scand Suppl; 1997; (224):10-1. PubMed ID: 9589706
    [No Abstract]   [Full Text] [Related]  

  • 18. Vascular endothelial growth factor and basic fibroblast growth factor present in Kaposi's sarcoma (KS) are induced by inflammatory cytokines and synergize to promote vascular permeability and KS lesion development.
    Samaniego F; Markham PD; Gendelman R; Watanabe Y; Kao V; Kowalski K; Sonnabend JA; Pintus A; Gallo RC; Ensoli B
    Am J Pathol; 1998 Jun; 152(6):1433-43. PubMed ID: 9626048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of vascular endothelial growth factor-associated tyrosine kinase activity with SU5416 blocks sprouting in the microvascular endothelial cell spheroid model of angiogenesis.
    Haspel HC; Scicli GM; McMahon G; Scicli AG
    Microvasc Res; 2002 May; 63(3):304-15. PubMed ID: 11969307
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequent administration of angiogenesis inhibitor TNP-470 (AGM-1470) at an optimal biological dose inhibits tumor growth and metastasis of metastatic human transitional cell carcinoma in the urinary bladder.
    Inoue K; Chikazawa M; Fukata S; Yoshikawa C; Shuin T
    Clin Cancer Res; 2002 Jul; 8(7):2389-98. PubMed ID: 12114444
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.